These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2746495)

  • 1. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.
    Bjornsson TD; Schneider DE; Berger H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):154-61. PubMed ID: 2746495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis in the rat after short-term aspirin therapy.
    Housholder GT; Moorrees LL
    J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
    Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of moderate alcohol ingestion on blood coagulation and fibrinolysis at rest and in response to exercise.
    el-Sayed MS; Eastland P; Lin X; Rattu AM
    J Sports Sci; 1999 Jun; 17(6):513-20. PubMed ID: 10404500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H; Takahashi H; Chiba K; Tamura K
    Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V; Pannell R
    Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S; Bark N; Wang H; Svensson J; Blombäck M
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.
    Tiefenbrunn AJ; Robinson AK; Kurnik PB; Ludbrook PA; Sobel BE
    Circulation; 1985 Jan; 71(1):110-6. PubMed ID: 4038368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids.
    Iacoviello L; Amore C; De Curtis A; Tacconi MT; de Gaetano G; Cerletti C; Donati MB
    Arterioscler Thromb; 1992 Oct; 12(10):1191-7. PubMed ID: 1390591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.